Medtronic (Minneapolis) reported the first patient was enrolled in its FIRE AND ICE clinical trial, which is a prospective, randomized, multinational head-to-head clinical trial comparing the long-term safety, effectiveness and ease-of-use of the Medtronic Arctic Front Cardiac CryoAblation System compared to the Biosense Webster (Diamond Bar, California) Carto System Guided Thermocool Catheter to treat patients with symptomatic paroxysmal atrial fibrillation. Read More
